Tailored Cancer Screenings On-Site: Empowering Employers with Advanced Preventive Care
On Site Health Diagnostics (OHD) now offers on-site cancer screenings including BEXA™ breast exams, FIT colorectal tests, CA-125 ovarian cancer testing, and gut biome cancer linkage analysis. Customizable programs tailored to your workforce.
In today’s healthcare landscape, early detection saves lives—plain and simple. At On Site Health Diagnostics (OSHD), we’re going beyond routine biometric screenings to bring employers the next generation of preventive cancer screening tools right to the workplace.
Through strategic partnerships and advanced laboratory capabilities, OSHD now offers customizable cancer screening panels that meet the evolving needs of employers and their employees. Whether you’re focused on high-risk groups, gender-specific conditions, or emerging health insights, our flexible approach delivers targeted screenings with minimal disruption and maximum impact.
Advanced Screening Capabilities Now Offered
We’ve expanded our portfolio to include the following cutting-edge cancer screening tests—all available as part of our tailored wellness programs:
🔬 BEXA™ Breast Cancer Screening
A non-invasive, FDA-cleared breast health assessment that uses tactile sensors and thermodynamic data to detect abnormalities earlier—especially in women under 40 or those with dense breast tissue. BEXA is portable, painless, and radiation-free, making it a breakthrough in accessibility and comfort.
Why it matters:
Early-stage breast cancer is more treatable and survivable. Offering BEXA on-site increases screening compliance, especially among populations historically underserved by traditional mammograms.
💩 FIT (Fecal Immunochemical Test)
This non-invasive, easy-to-use at-home test detects hidden blood in the stool—a potential early sign of colorectal cancer.
Why it matters:
Colorectal cancer is one of the most preventable forms of cancer with regular screening. FIT is simple, affordable, and requires no dietary restrictions.
🧪 CA-125 Ovarian Cancer Screening
This blood test measures the level of cancer antigen 125, which can be elevated in women with ovarian cancer.
Why it matters:
Ovarian cancer is often detected late due to vague symptoms. Screening high-risk populations can significantly shift outcomes toward early intervention and survival.
🧬 Gut Biome Cancer Linkage Test
This innovative stool test evaluates microbial markers linked to GI cancers and systemic inflammation. It offers insight into how gut health correlates with cancer risk and overall immune system function.
Why it matters:
There’s growing evidence linking gut dysbiosis to colorectal and other forms of cancer. This test supports proactive health strategies and deeper understanding of long-term risk factors.
Why Employers Choose OSHD
One-size-fits-all health programs are over. Employers today want targeted solutions that reflect their population’s risk profile, lifestyle, and demographics. Our modular screening approach enables businesses to:
- Customize screening packages by age, gender, risk, or claims data
- Improve participation with on-site, concierge-style service
- Offer actionable results through our integrated data dashboard
- Control healthcare costs by catching serious illness early
- Enhance employee engagement with meaningful, personalized care
We handle everything—from logistics and clinical oversight to result interpretation and follow-up coordination. Most importantly, your employees receive timely, confidential results with clear next steps for care.
Let’s Build a Smarter Screening Strategy
The future of workplace health is personal, predictive, and proactive. At On Site Health Diagnostics, we’re delivering it today—with technology, clinical depth, and partnerships that make a difference.
Ready to tailor your cancer screening offerings?
Contact us at info@onsitehd.com or call 877-366-7483 to schedule a consult. Your team deserves the best chance at early detection—and you deserve a screening program built for outcomes, not just checkboxes.